Dysmenorrhoea: Can Medicinal Cannabis Bring New Hope for a Collective Group of Women Suffering in Pain, Globally?
Dysmenorrhoea effects up to 90% of women of reproductive age, with medical management options including over-the-counter analgesia or hormonal contraception. There has been a recent surge in medicinal cannabis research and its analgesic properties. This paper aims to critically investigate the curre...
Main Authors: | Amelia Seifalian, Julian Kenyon, Vik Khullar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/24/16201 |
Similar Items
-
Chemistry, Metabolism, and Toxicology of Cannabis: Clinical Implications
by: M.M. Srinivas Bharath, et al.
Published: (2012-12-01) -
Recreational cannabis: Profile of cannabinoids present in marijuana samples supplied by the consuming population
by: Santiago Gómez Velásquez, et al.
Published: (2023-03-01) -
A Proteomic View of Cellular and Molecular Effects of Cannabis
by: Morteza Abyadeh, et al.
Published: (2021-09-01) -
Priority areas for cannabis and cannabinoid product research in South Africa
by: Tanya N. Augustine, et al.
Published: (2018-06-01) -
Women’s experiences of dysmenorrhoea – preliminary study
by: Urszula Tataj-Puzyna, et al.
Published: (2021-10-01)